Bandelow Borwin, Reitt Markus, Röver Christian, Michaelis Sophie, Görlich Yvonne, Wedekind Dirk
Departments of aPsychiatry and Psychotherapy bMedical Statistics, University of Göttingen, Göttingen, Germany.
Int Clin Psychopharmacol. 2015 Jul;30(4):183-92. doi: 10.1097/YIC.0000000000000078.
To our knowledge, no previous meta-analysis has attempted to compare the efficacy of pharmacological, psychological and combined treatments for the three main anxiety disorders (panic disorder, generalized anxiety disorder and social phobia). Pre-post and treated versus control effect sizes (ES) were calculated for all evaluable randomized-controlled studies (n = 234), involving 37,333 patients. Medications were associated with a significantly higher average pre-post ES [Cohen's d = 2.02 (1.90-2.15); 28,051 patients] than psychotherapies [1.22 (1.14-1.30); 6992 patients; P < 0.0001]. ES were 2.25 for serotonin-noradrenaline reuptake inhibitors (n = 23 study arms), 2.15 for benzodiazepines (n = 42), 2.09 for selective serotonin reuptake inhibitors (n = 62) and 1.83 for tricyclic antidepressants (n = 15). ES for psychotherapies were mindfulness therapies, 1.56 (n = 4); relaxation, 1.36 (n = 17); individual cognitive behavioural/exposure therapy (CBT), 1.30 (n = 93); group CBT, 1.22 (n = 18); psychodynamic therapy 1.17 (n = 5); therapies without face-to-face contact (e.g. Internet therapies), 1.11 (n = 34); eye movement desensitization reprocessing, 1.03 (n = 3); and interpersonal therapy 0.78 (n = 4). The ES was 2.12 (n = 16) for CBT/drug combinations. Exercise had an ES of 1.23 (n = 3). For control groups, ES were 1.29 for placebo pills (n = 111), 0.83 for psychological placebos (n = 16) and 0.20 for waitlists (n = 50). In direct comparisons with control groups, all investigated drugs, except for citalopram, opipramol and moclobemide, were significantly more effective than placebo. Individual CBT was more effective than waiting list, psychological placebo and pill placebo. When looking at the average pre-post ES, medications were more effective than psychotherapies. Pre-post ES for psychotherapies did not differ from pill placebos; this finding cannot be explained by heterogeneity, publication bias or allegiance effects. However, the decision on whether to choose psychotherapy, medications or a combination of the two should be left to the patient as drugs may have side effects, interactions and contraindications.
据我们所知,此前尚无荟萃分析尝试比较药物治疗、心理治疗及联合治疗对三种主要焦虑症(惊恐障碍、广泛性焦虑症和社交恐惧症)的疗效。对所有可评估的随机对照研究(n = 234)进行前后测及治疗组与对照组效应量(ES)计算,涉及37333例患者。药物治疗的前后测平均ES显著高于心理治疗[科恩d值 = 2.02(1.90 - 2.15);28051例患者],心理治疗的ES为1.22(1.14 - 1.30);6992例患者;P < 0.0001。5 - 羟色胺 - 去甲肾上腺素再摄取抑制剂的ES为2.25(n = 23个研究组),苯二氮䓬类药物为2.15(n = 42),选择性5 - 羟色胺再摄取抑制剂为2.09(n = 62),三环类抗抑郁药为1.83(n = 15)。心理治疗的ES为:正念疗法,1.56(n = 4);放松疗法,1.36(n = 17);个体认知行为/暴露疗法(CBT),1.30(n = 93);团体CBT,1.22(n = 18);心理动力疗法1.17(n = 5);非面对面接触疗法(如网络疗法),1.11(n = 34);眼动脱敏再处理疗法,1.03(n = 3);人际疗法0.78(n = 4)。CBT/药物联合治疗的ES为2.12(n = 16)。运动的ES为1.23(n = 3)。对照组中,安慰剂药丸的ES为1.29(n = 111),心理安慰剂为0.83(n = 16),等待名单为0.20(n = 50)。与对照组直接比较时,除西酞普兰、奥匹哌醇和吗氯贝胺外,所有研究药物均比安慰剂显著更有效。个体CBT比等待名单、心理安慰剂和药丸安慰剂更有效。从前后测平均ES来看,药物治疗比心理治疗更有效。心理治疗的前后测ES与药丸安慰剂无差异;这一发现无法用异质性、发表偏倚或忠诚效应来解释。然而,关于选择心理治疗、药物治疗还是两者联合治疗的决定应留给患者,因为药物可能有副作用、相互作用和禁忌证。